GSK
681 hedge funds and large institutions have $14.4B invested in GSK in 2013 Q4 according to their latest regulatory filings, with 94 funds opening new positions, 265 increasing their positions, 204 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
7% more funds holding
Funds holding: 635 → 681 (+46)
7% more capital invested
Capital invested by funds: $13.5B → $14.4B (+$883M)
0.04% more ownership
Funds ownership: 4.38% → 4.42% (+0.04%)
Holders
681
Holding in Top 10
15
Calls
$164M
Puts
$63.5M
Top Buyers
| 1 | +$274M | |
| 2 | +$135M | |
| 3 | +$110M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$79.3M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$70.6M |
Top Sellers
| 1 | -$191M | |
| 2 | -$170M | |
| 3 | -$82.8M | |
| 4 |
EAM
Edge Asset Management
Seattle,
Washington
|
-$78M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$58.6M |